JaxBio Technologies Raises €2.5M for Lung Cancer Blood Test

JaxBio Technologies receives €2.5M Grant from European Innovation Council

JaxBio Technologies (Linkedin), a medical diagnostics company based in Israel, has been awarded a €2.5M grant from the European Innovation Council (EIC) Accelerator. With potential additional funding of €9.1M from the EU and other investors, JaxBio aims to develop a blood test for simplified and accurate lung cancer detection and management using their liquid biopsy technology.

Funding Amount: €2.5 million grant, with potential additional funding

Industry: Hospitals and Health Care

Employee Count: 11-50

CEO: Shahar Zirkin (CEO Linkedin)

What JaxBio Technologies needs to buy: JaxBio Technologies is seeking research and development partnerships, manufacturing and supply chain solutions, and marketing and sales support. Companies specializing in diagnostic solutions, research institutions, biotech companies, and manufacturers can collaborate with JaxBio to advance their diagnostic platform, expand biomarker detection capabilities, and promote and sell their innovative products to healthcare providers and institutions.